Hospira Inc. issued a retail-level recall of certain lots of its Ketorolac Tromethamine Injection, USP, after receiving a customer report of particulate matters in the vials, according to a statement published by the U.S. Food and Drug Administration (FDA) on February 10.
The company urges all the stakeholders to visit the FDA website for the list of the affected units. The recalled injections were sold in the country between February 2013 and December 2014. The affected medical facilities and retailers that further distributed the products are urged to notify any facility that may have received the vials.
Administering an injection with a particulate matter may cause injurious, sometimes fatal health complications, such as allergic reaction and inflammation. If you have been hurt because of a contaminated injection or any other medical product in Madison, a product liability lawyer at Habush Habush & Rottier S.C. ® can help you assess if your situation qualifies you for a legal claim. Call us at (414) 271-0900 to learn more about your legal options today.